Copyright
©The Author(s) 2020.
World J Crit Care Med. Jan 31, 2020; 9(1): 1-12
Published online Jan 31, 2020. doi: 10.5492/wjccm.v9.i1.1
Published online Jan 31, 2020. doi: 10.5492/wjccm.v9.i1.1
Cytokine (pg) | Pre CytoSorb® therapy | Post CytoSorb® therapy | Percentage change | P value |
IL-1 | 5.52 ± 2.59 | 5.79 ± 2.55 | 4.89 | 0.7364 |
IL-6 | 2273.51 ± 1212.82 | 2638.24 ± 1518.26 | 16.04 | 0.1486 |
IL-10 | 296.00 ± 146.4 | 295.67 ± 112.00 | -0.111 | 0.9894 |
TNF | 19.43 ± 6.07 | 20.40 ± 6.26 | 5.00 | 0.3914 |
- Citation: Mehta Y, Mehta C, Kumar A, George JV, Gupta A, Nanda S, Kochhar G, Raizada A. Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients. World J Crit Care Med 2020; 9(1): 1-12
- URL: https://www.wjgnet.com/2220-3141/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v9.i1.1